Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Xerostomia 1Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Radiation Injuries 1Prostatic Neoplasms 1Mucositis 1Lung Neoplasms 1Kidney Neoplasms 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Carboplatin 12Bevacizumab 10Radiotherapy 9Paclitaxel 9Erlotinib Hydrochloride 9Pemetrexed 7Docetaxel 5Taxes 4Cisplatin 4pegfilgrastim 3Gemcitabine 3Cetuximab 3Radiotherapy, Conformal 2Filgrastim 2veliparib 1romidepsin 1pegylated granulocyte colony-stimulating factor 1lentiviral minigene vaccine of COVID-19 coronavirus 1Watchful Waiting 1Vinorelbine 1Topotecan 1Thalidomide 1Temozolomide 1Surgical Procedures, Operative 1Sorafenib 1Selenomethionine 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Radiation 1Pneumonectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Adenocarcinoma, Bronchiolo-Alveolar × Selenomethionine × Clear all
NCT00526890 2017-11-28

Carboplatin, Paclitaxel, Selenomethionine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Roswell Park Cancer Institute

Phase 2 Terminated
16 enrolled 11 charts
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡